Use of Recentin Helps Stabilize Rare Sarcoma Subset 🔗 Access full article via CureTodayUsing Recentin (cediranib) can help stabilize disease in patients with alveolar soft-part sarcoma, a rare sarcoma subset. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon